Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Chinese Journal of Lung Cancer
1009-3419
2012 Issue 3
Mutation of the BRAF Genes in Non-small Cell Lung Cancer
Zhimin HUANG;Yilong WU Division of Pulmonary Oncology;Guangdong Lung Cancer Institute;Guangdong General Hospital and Guangdong Academy of Medical Sciences;Guangzhou 510080;China
..............page:183-186
Establishment of Animal Model of A Human Lung Adenocarcinoma Drug-resistant Cell Line Anip973/NVB and Investigation on Mechanism of Drug Resistance
Meng WANG1;Xuan HONG1;Qinwen SUN2;Ruilin LI3;Zhaoyang YANG1;Gongyan CHEN1 1Department of Medical Oncology;the Third Affiliated Hospital of Harbin Medical University;Harbin 150081;China;2Department of Medical Oncology;Thoracic Hospital of Harbin City;Harbin 150001;China;3Department of Medical Oncology;Hospital of Weihai City;Weihai 264200;China
..............page:146-151
ren fei xian ai anip973/nvb nai yao xi bao xi dong wu mo xing de jian li ji qi nai yao ji zhi de yan jiu
wang meng hong zuo sun qin wen li rui lin yang chao yang chen gong zuo
..............page:146-147-148-149-150-151
Vandetanib for Advanced Non-small Cell Lung Cancer:A Meta-analysis
Ling TAO;Wenlei ZHUO;Fan YANG;Bo ZHU Institute of Cancer;Xinqiao Hospital;the Third Military Medical University;Chongqing 400037;China
..............page:172-178
pei mei qu sai zai wan qi fei xiao xi bao fei ai er xian ji yi shang zhi liao zhong de liao xiao fen xi
li jun ling wang jing hao xue zhi zhang xiang ru shi yuan kai
..............page:179-180-181-182
fei xiao xi bao fei ai de braf ji yin tu bian ji qi lin chuang yi yi
huang zhi min wu yi long
..............page:183-184-185-186
fan de ta ni zhi liao fei xiao xi bao fei ai de meta fen xi
tao ling zhuo wen lei yang fan zhu bo
..............page:172-173-174-175-176-177-178
wo guo yun nan qu jing fei ai gao fa qu huan jing liu xing bing xue diao cha yan jiu
zhang lin lin li ji hua wang ya jie wu guo ping wei fu sheng
..............page:159-160-161-162-163
Lentivirus-mediated Stable Silencing of nm23-H1 Gene in Lung Cancer Cells and the Influence on Biological Behavior
Meng LUO1;2;Daxing ZHU1Lei GONG1;Xiaoming QIU1;Lingling ZU1;Liya SUN1;Zhihao WU1;Qinghua ZHOU1 Meng LUO and Daxing ZHU contributed equally to this paper.1Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment;Tianjin Lung Cancer Institute;Tianjin Medical University General Hospital;Tianjin 300052;China;2Department of Thoracic Surgery;the Hospital of Guizhou Province;Guiyang 550002;China
..............page:139-145
Clinical Significance of T Lymphocyte Subset Changes After First Line Chemotherapy in Peripheral Blood from Patients with Advanced Stage Adenocarcinoma Cell Lung Cancer
Xiang YAN;Xiao ZHAO;Shunchang JIAO;Shengjie SUN;Liangliang WU;Zhiyong WU Department of Medical Oncology;the PLA General Hospital;Beijing 100853;China
..............page:164-171
wan qi fei xian ai huan zhe yi xian hua liao hou t lin ba xi bao ya qun bian hua ji lin chuang yi yi
yan xiang zhao xiao jiao shun chang sun sheng jie wu liang liang wu zhi yong
..............page:164-165-166-167-168-169-170-171
hpv he fei ai guan xi de yan jiu jin zhan
guo feng jie fan ya guang qiao you lin zhou qing hua
..............page:191-192-193-194
Study Advance of Relationship between HPV and Lung Cancer
Fengjie GUO1;Yaguang FAN1;Youlin QIAO2;Qinghua ZHOU1 1Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment;Tianjin Lung Cancer Institute;Tianjin Medical University General Hospital;Tianjin 300052;China;2Cancer Institute;Peking Union Medical College and Chinese Academy of Medical Sciences;Beijing 100021;China
..............page:191-194
Side Population Cells and Lung Cancer Stem Cells
Zhenhua PAN;Qinghua ZHOU Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment;Tianjin Lung Cancer Institute;Tianjin Medical University General Hospital;Tianjin 300052;China
..............page:187-190
Descriptive Study of the Environmental Epidemiology of High Lung Cancer Incidence Rate in Qujing,Yunnan,China
Linlin ZHANG1;Jihua LI2;Yajie WANG3;Guoping WU1;Fusheng WEI1 1National Environmental Monitoring Center;Beijing 100012;China;2Qujing Centers for Disease Control and Prevention;Qujing 655000;China 3China Gao Xin Investment Group Corporation;Beijing 100055;China
..............page:159-163
duo xi ta sai yu ji fei ti ni xu guan ying yong dui ren fei xian ai xi bao h1975 cun huo ji diao wang tong lu de yan jiu
zhang zuo yu liu zuo yang zhu xiao guang wang wei lan
..............page:127-128-129-130-131-132-133-134-135-136-137-138
man bing du jie dao de wen ding chen mo nm23-h1 ji yin de fei ai xi bao zhu de jian li ji sheng wu xue xing wei gai bian
luo meng zhu da xing gong lei qiu xiao ming zu ling ling sun li ya wu zhi hao zhou qing hua
..............page:139-140-141-142-143-144-145
wen ding biao da ying guang su mei de nm23-h1 biao da que shi ren fei xian ai xi bao zhu de gou jian ji qi ti nei wai huo xing jian ce
wang hong ming zhu da xing wu zhi hao zhou qing hua
..............page:152-153-154-155-156-157-158
ce qun xi bao yu fei ai zhong liu gan xi bao
pan zhen hua zhou qing hua
..............page:187-188-189-190
Establishment of the Cell Line that Human Lung Adenocarcinoma can Stably Express Luciferase Which is Absent of nm23-H1 Expression and Detecting Its Luminescence in vitro and in vivo
Hongming WANG;Daxing ZHU;Zhihao WU;Qinghua ZHOU Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment;Tianjin Lung Cancer Institute;Tianjin Medical University General Hospital;Tianjin 300052;China
..............page:152-158
Sequence-dependent Effect of Docetaxel with Gefitinib on the Proliferation and Apoptosis of Lung Adenocarcinoma Cell H1975
Xinyu ZHANG1;Guiyang LIU2;Xiaoguang ZHU1;Weilan WANG3 1Department of Pharmacy;Bengbu Medical College;Bengbu 233000;China;2Department of Pharmacy;the Affiliated Hospital of Chinese PLA Hospital;Beijing 100853;China;3Department of Pharmaceutical Care;PLA General Hospital;Beijing 100853;China
..............page:127-138
Efficacy of Pemetrexed as Second-line Therapy or Beyond in Patients with Advanced Non-small Cell Lung Cancer
Junling LI;Jing WANG;Xuezhi HAO;Xiangru ZHANG;Yuankai SHI Cancer Institute and Hospital;Chinese Academy of Medical Sciences and Peking Union Medical College;Beijing 100021;China
..............page:179-182